This year at the European Molecular Imaging Meeting in Glasgow, MILabs is hosting an Industry Session on the past, present and future of multi-modal imaging technology, with presentations from the UMC Utrecht (the Netherlands), RWTH Aachen (Germany), Newcastle University (United Kingdom) and Radboud UMC Nijmegen (the Netherlands).
I would personally like to invite you to join us during this session. It’s on Thursday, 21st of March, from 08:30 until 10:00 in the Biosdale room at level 0. See you in Glasgow!
Founder and CEO MILabs
08:30h Freek Beekman, PhD
Founder & CEO MILabs – The Netherlands High-Performance and Fully Integrated PET, SPECT, Optical & X-ray CT
08:50h Felix Gremse, PhD
RWTH Aachen – Germany Non-Invasive Biodistribution Assessment Using Hybrid Fluorescence and X-Ray CT Tomography
09:05h Behdad Pouran, PhD
UMC Utrecht – The Netherlands Multi-Scale CT Imaging of Calcified Tissues In-Vivo and Ex-Vivo
09:20h James Knight, PhD
Newcastle University – United Kingdom Simultaneous Dual Isotope PET-SPECT Antibody Imaging and PARP Imaging with [18F]Olaparib
09:40h René Raavé, PhD
Radboud UMC Nijmegen – The Netherlands Developing Nuclear Tracers for Imaging of Immune Cells During Immunotherapy
Thursday, March 21
08:30 – 10:00
Meet us at:
EMIM, March 19 – 22 2019, Glasgow
AACR, March 30 – April 3 2019, Atlanta
NukMed, April 3 – 6 2019, Bremen
ISRS, May 26 – 31 2019, Beijing
SNMMI, June 22 – 25 3 2019, Anaheim
EANM, October 12-16, Barcelona
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.